{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:25:50Z","timestamp":1791663950262,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.anaerobe.2019.102072","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T12:01:29Z","timestamp":1563537689000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-3298","authenticated-orcid":false,"given":"Srishti","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saloni","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raseen","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey N.","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritish K.","family":"Tosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.anaerobe.2019.102072_bib1","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9","key":"10.1016\/j.anaerobe.2019.102072_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.idc.2014.11.003","article-title":"The morbidity, mortality, and costs associated with Clostridium difficile infection","volume":"29","author":"Kwon","year":"2015","journal-title":"Infect. Dis. Clin. N. Am."},{"issue":"9","key":"10.1016\/j.anaerobe.2019.102072_bib4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"5","key":"10.1016\/j.anaerobe.2019.102072_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00004836-200405000-00005","article-title":"Factors associated with failure of metronidazole in Clostridium difficile-associated disease","volume":"38","author":"Fernandez","year":"2004","journal-title":"J.\u00a0Clin. Gastroenterol."},{"issue":"11","key":"10.1016\/j.anaerobe.2019.102072_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin. infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.anaerobe.2019.102072_bib7","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/j.1572-0241.2007.01539.x","article-title":"Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1\/027","volume":"102","author":"P\u00e9pin","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.anaerobe.2019.102072_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cmi.2014.09.017","article-title":"Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes","volume":"21","author":"Freeman","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2019.102072_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","article-title":"Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model","volume":"45","author":"Doi","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.anaerobe.2019.102072_bib12","series-title":"Cochrane Handbook for Systematic Reviews of Interventions the Cochrane Collaboration","author":"Higgins","year":"2011"},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diagmicrobio.2015.05.015","article-title":"A\u00a0national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole","volume":"83","author":"Adler","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.102072_bib14","first-page":"12","article-title":"Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland","volume":"12","author":"Aptekorz","year":"2017","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12223-013-0283-1","article-title":"Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains","volume":"59","author":"Beran","year":"2014","journal-title":"Folia Microbiol."},{"issue":"6","key":"10.1016\/j.anaerobe.2019.102072_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/IPC.0b013e3181f0c020","article-title":"Characterization of clostridium difficile infection and analysis of recovered isolates in a community hospital population in Baltimore, Maryland","volume":"18","author":"Saatian","year":"2010","journal-title":"Infect. Dis. Clin. Pract."},{"issue":"7","key":"10.1016\/j.anaerobe.2019.102072_bib17","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/AAC.02775-13","article-title":"Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013","volume":"58","author":"Tickler","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8 Supplement 1","key":"10.1016\/j.anaerobe.2019.102072_bib18","first-page":"88","article-title":"Diversity of clinical Clostridium difficile isolates in sporulation and growth capacities","volume":"306","author":"Plorin","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.anaerobe.2019.102072_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bjid.2016.07.004","article-title":"Antimicrobial susceptibility of Brazilian Clostridium difficile strains determined by agar dilution and disk diffusion","volume":"20","author":"Fraga","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2019.102072_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2334-10-363","article-title":"Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection","volume":"10","author":"Gonzales","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.anaerobe.2019.102072_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.anaerobe.2019.102072_bib23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jiac.2018.05.010","article-title":"Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan","volume":"24","author":"Mikamo","year":"2018","journal-title":"J.\u00a0Infect. Chemother."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/588293","article-title":"Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin","volume":"47","author":"Al-Nassir","year":"2008","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hemonc.2018.05.001","article-title":"Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant","volume":"11","author":"Prohaska","year":"2018","journal-title":"Hematol. Oncol. Stem Cells Ther."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijantimicag.2015.03.016","article-title":"Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection","volume":"46","author":"Thabit","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"11","key":"10.1016\/j.anaerobe.2019.102072_bib27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among us hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Int. Med."},{"issue":"8","key":"10.1016\/j.anaerobe.2019.102072_bib28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"15","key":"10.1016\/j.anaerobe.2019.102072_bib29","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib32","first-page":"267","article-title":"Antimicrobial resistance and reduced susceptibility in Clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection","volume":"4","author":"Baines","year":"2015","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1469-0691.2000.00034-4.x","article-title":"Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile","volume":"6","author":"Poilane","year":"2000","journal-title":"Clin. Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dks420","article-title":"Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes","volume":"68","author":"Moura","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.anaerobe.2019.102072_bib35","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/JCM.00524-08","article-title":"Metronidazole resistance in Clostridium difficile is heterogeneous","volume":"46","author":"Pel\u00e1ez","year":"2008","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmi.2017.07.012","article-title":"Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970","volume":"24","author":"Khanafer","year":"2018","journal-title":"Clin. Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib37","first-page":"13","article-title":"Predominance of Clostridium difficile 027 during a five-year period in bolzano, northern Italy","volume":"25","author":"Aschbacher","year":"2017","journal-title":"Inf. Med."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/JCM.01898-16","article-title":"Molecular epidemiology of clostridium difficile infection in hospitalized patients in eastern China","volume":"55","author":"Jin","year":"2017","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2019.102072_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nmni.2016.09.002","article-title":"Emergence and spread of moxifloxacin-resistant Clostridium difficile ribotype 231 in Sweden between 2006 and 2015","volume":"14","author":"Harvala","year":"2016","journal-title":"N.\u00a0Microbes N. Infect."},{"issue":"8","key":"10.1016\/j.anaerobe.2019.102072_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161411","article-title":"Surveillance of antibiotic resistance among hospital- and community-acquired toxigenic Clostridium difficile isolates over 5-year period in Kuwait","volume":"11","author":"Jamal","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.anaerobe.2019.102072_bib41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ijmm.2016.09.004","article-title":"High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana","volume":"306","author":"Janssen","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.anaerobe.2019.102072_bib42","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/AAC.00714-16","article-title":"Differences in the molecular epidemiology and antibiotic susceptibility of Clostridium difficile isolates in pediatric and adult patients","volume":"60","author":"Kociolek","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12879-016-1618-8","article-title":"Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection","volume":"16","author":"Peretz","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0950268815000837","article-title":"Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease","volume":"144","author":"Samonis","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.anaerobe.2019.102072_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.anaerobe.2016.01.005","article-title":"Clostridium difficile recurrences in Stockholm","volume":"38","author":"Sandell","year":"2016","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151964","article-title":"Molecular characterization of Clostridium difficile isolates from human subjects and the environment","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.anaerobe.2019.102072_bib47","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1093\/jac\/dkv220","article-title":"Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14","volume":"70","author":"Knight","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tvjl.2015.09.001","article-title":"Investigation of Clostridium difficile interspecies relatedness using multilocus sequence typing, multilocus variable-number tandem-repeat analysis and antimicrobial susceptibility testing","volume":"206","author":"Rodriguez","year":"2015","journal-title":"Vet. J."},{"issue":"10","key":"10.1016\/j.anaerobe.2019.102072_bib49","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/AAC.00845-15","article-title":"U.S.-Based national sentinel surveillance study for the epidemiology of clostridium difficile-associated diarrheal isolates and their susceptibility to fidaxomicin","volume":"59","author":"Snydman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2019.102072_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.anaerobe.2014.10.003","article-title":"Antibiotic resistance patterns and PCR-ribotyping of Clostridium difficile strains isolated from swine and dogs in Italy","volume":"31","author":"Spigaglia","year":"2015","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib51","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.01820-15","article-title":"Fluoroquinolone and macrolide exposure predict Clostridium difficile infection with the highly fluoroquinolone- and macrolide-resistant epidemic C. difficile strain BI\/NAP1\/027","volume":"60","author":"Wieczorkiewicz","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.anaerobe.2019.102072_bib52","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1086\/678070","article-title":"Clinical and molecular characteristics of an outbreak caused by the pandemic (BI\/NAP1\/027) Clostridium difficile clone in a single center in Israel","volume":"35","author":"Wiener-Well","year":"2014","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"3\u20134","key":"10.1016\/j.anaerobe.2019.102072_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.vetmic.2013.12.018","article-title":"Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazole-resistant isolate from a zebra foal (Equus quagga burchellii)","volume":"169","author":"Alvarez-Perez","year":"2014","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12879-014-0607-z","article-title":"Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich","volume":"14","author":"Buchler","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"10.1016\/j.anaerobe.2019.102072_bib55","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3760\/cma.j.issn.0366-6999.20132724","article-title":"Clinical and microbiological characterization of Clostridium difficile infection in a tertiary care hospital in Shanghai, China","volume":"127","author":"Dong","year":"2014","journal-title":"Chin. Med. J."},{"issue":"PART 2","key":"10.1016\/j.anaerobe.2019.102072_bib56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1099\/jmm.0.066399-0","article-title":"Spread of epidemic clostridium difficile NAP1\/027 in Latin America: case reports in Panama","volume":"63","author":"Lopez-Urena","year":"2014","journal-title":"J.\u00a0Med. Microbiol."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/fpd.2013.1648","article-title":"Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas","volume":"11","author":"Norman","year":"2014","journal-title":"Foodb. Pathog. Dis."},{"key":"10.1016\/j.anaerobe.2019.102072_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.anaerobe.2014.07.007","article-title":"First clinical and microbiological characterization of clostridium difficile infection in a Croatian University hospital","volume":"30","author":"Novak","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2019.102072_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anaerobe.2014.04.007","article-title":"Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010","volume":"28","author":"Obuch-Woszczatynski","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2019.102072_bib60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.anaerobe.2014.05.013","article-title":"Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain","volume":"28","author":"Secco","year":"2014","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.anaerobe.2019.102072_bib61","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1590\/S0103-84782014000500013","article-title":"Antimicrobial susceptibility of Clostridium difficile isolated from animals and humans in Brazil","volume":"44","author":"Silva","year":"2014","journal-title":"Ci\u00eancia Rural."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.rvsc.2013.06.021","article-title":"High prevalence of the epidemic Clostridium difficile PCR ribotype 078 in Iberian free-range pigs","volume":"95","author":"\u00c1lvarez-P\u00e9rez","year":"2013","journal-title":"Res. Vet. Sci."},{"issue":"10","key":"10.1016\/j.anaerobe.2019.102072_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075471","article-title":"Molecular epidemiology of Clostridium difficile at a medical center in taiwan: persistence of genetically clustering of A-B+ isolates and increase of A+B+ isolates","volume":"8","author":"Chia","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.anaerobe.2019.102072_bib64","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5812\/ircmj.5189","article-title":"Antimicrobial susceptibility of clostridium difficile clinical isolates in Iran","volume":"15","author":"Goudarzi","year":"2013","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.anaerobe.2019.102072_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.anaerobe.2013.05.009","article-title":"Characterization of swine isolates of clostridium difficile in Spain: a potential source of epidemic multidrug resistant strains?","volume":"22","author":"Pel\u00e1ez","year":"2013","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030594","article-title":"Clostridia in premature neonates' gut: incidence, antibiotic susceptibility, and perinatal determinants influencing colonization","volume":"7","author":"Ferraris","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.anaerobe.2019.102072_bib67","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1017\/S0950268811002627","article-title":"Seasonality of Clostridium difficile infections in southern Germany","volume":"140","author":"Reil","year":"2012","journal-title":"Epidemiol. Infect."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib68","first-page":"307","article-title":"Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates","volume":"35","author":"Russello","year":"2012","journal-title":"New Microbiol."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/00365548.2011.631029","article-title":"Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1\/BI\/027 setting","volume":"44","author":"Venugopal","year":"2012","journal-title":"Scand. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10482-010-9483-8","article-title":"Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil","volume":"99","author":"Balassiano","year":"2011","journal-title":"Antonie Leeuwenhoek"},{"issue":"1332","key":"10.1016\/j.anaerobe.2019.102072_bib71","first-page":"45","article-title":"Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009","volume":"124","author":"Roberts","year":"2011","journal-title":"N.\u00a0Z. Med. J."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2010.07.017","article-title":"An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil","volume":"68","author":"Balassiano","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jcp.2009.071688","article-title":"In\u00a0vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas","volume":"63","author":"Jiang","year":"2010","journal-title":"J.\u00a0Clin. Pathol."},{"issue":"10","key":"10.1016\/j.anaerobe.2019.102072_bib74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10096-010-0997-9","article-title":"Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease","volume":"29","author":"Wultanska","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.anaerobe.2019.102072_bib75","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.anaerobe.2009.09.005","article-title":"Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection","volume":"15","author":"Citron","year":"2009","journal-title":"Anaerobe"},{"issue":"10","key":"10.1016\/j.anaerobe.2019.102072_bib76","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajic.2009.05.001","article-title":"Clostridium difficile infections among Jordanian adult hospitalized patients","volume":"37","author":"Nasereddin","year":"2009","journal-title":"Am. J. Infect. Contr."},{"issue":"12","key":"10.1016\/j.anaerobe.2019.102072_bib77","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-008-0564-9","article-title":"Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007","volume":"27","author":"Fenner","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.anaerobe.2019.102072_bib78","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1128\/JCM.00306-07","article-title":"Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland","volume":"45","author":"Pituch","year":"2007","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.anaerobe.2019.102072_bib79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diagmicrobio.2006.12.007","article-title":"Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins","volume":"58","author":"Pituch","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diagmicrobio.2005.09.008","article-title":"Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel","volume":"54","author":"Bishara","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diagmicrobio.2004.12.015","article-title":"Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital","volume":"52","author":"Martirosian","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.anaerobe.2019.102072_bib82","first-page":"465","article-title":"Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.[Erratum appears in Equine Vet J. 2003 Nov;35(7):706]","volume":"35","author":"Baverud","year":"2003","journal-title":"Equine Vet. J."},{"issue":"Pt 12","key":"10.1016\/j.anaerobe.2019.102072_bib83","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1099\/jmm.0.05308-0","article-title":"Incidence and importance of Clostridium difficile in paediatric diarrhoea in Brazil","volume":"52","author":"Pinto","year":"2003","journal-title":"J.\u00a0Med. Microbiol."},{"issue":"4","key":"10.1016\/j.anaerobe.2019.102072_bib84","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0924-8579(02)00180-2","article-title":"In\u00a0vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait","volume":"20","author":"Jamal","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.anaerobe.2019.102072_bib85","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pel\u00e1ez","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.anaerobe.2019.102072_bib86","first-page":"156","article-title":"Antimicrobial susceptibility of Clostridium difficile strains isolated from hospitalised patients with acute diarrhoea","volume":"10","author":"Niyogi","year":"1992","journal-title":"J.\u00a0Diarrhoeal Dis. Res."},{"issue":"2","key":"10.1016\/j.anaerobe.2019.102072_bib87","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/22.2.167","article-title":"Antimicrobial susceptibility of Clostridium difficile determined by disc diffusion and breakpoint methods","volume":"22","author":"Levett","year":"1988","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.anaerobe.2019.102072_bib88","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/jcm.16.6.1096-1101.1982","article-title":"Investigation of an outbreak of antibiotic-associated colitis by various typing methods","volume":"16","author":"Wust","year":"1982","journal-title":"J.\u00a0Clin. Microbiol."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996419301222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996419301222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:37:33Z","timestamp":1761035853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996419301222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":88,"alternative-id":["S1075996419301222"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2019.102072","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2019.102072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}